Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arsenic Trioxide and Vitamin C

Research Papers that Mention the Interaction

In this study, we evaluated the effect of ATO plus AA in patients with non-APL AML.
The combination of ATO and AA has limited clinical meaningful antileukemia activity in patients with non-APL AML.
Annals of Hematology  •  2014  |  View Paper
Reducing glutathione by ascorbic acid may enhance the efficacy of arsenic trioxide.
Haematologica  •  2006  |  View Paper
We have reported that ascorbic acid (AA) enhances the activity of arsenic trioxide ( As(2)0(3)) against drug-resistant MM in vitro by depleting intracellular glutathione (GSH).
Clinical cancer research : an official journal of the American Association for Cancer Research  •  2002  |  View Paper
As2O3-induced apoptosis was not enhanced by ascorbic acid in normal cells, suggesting that the combination of ascorbic acid and As2O3 may be selectively toxic to some malignant cells.
Ascorbic acid enhanced the antilymphoma effect of As2O3 in vivo without additional toxicity.
Blood  •  1999  |  View Paper
These two genes might play critical roles in synergetic effects of AA and As2O3 , although the exact mechanism needs further investigation.
European review for medical and pharmacological sciences  •  2014  |  View Paper
However, vitamin C enhanced the growth inhibition, death, MMP (∆ψm) loss and GSH depletion by ATO and even strongly increased mitochondrial O2•- levels in ATO-treated HPF cells.
Oncology reports  •  2012  |  View Paper
While both ATO and ascorbic acid mediate cytotoxicity in CLL B cells as single agents, the efficacy of ATO is enhanced by ascorbic acid.
Leukemia research  •  2010  |  View Paper
The combination of arsenic trioxide with subtoxic concentrations of ascorbic acid resulted in a sensitization to apoptotic cell death.
Free radical biology & medicine  •  2009  |  View Paper
On the basis of these direct in vitro findings, our studies provide evidence that AA may extend the therapeutic spectrum of ATO.
The results of MTT assay indicated that AA exposure potentiates the cytotoxicity of ATO in HL‐60 cells, as evidenced by a gradual increase in MDA levels with increasing doses of AA.
Journal of biochemical and molecular toxicology  •  2008  |  View Paper
In MM, the combination regimens under study incorporate ascorbic acid , which can enhance the efficacy of arsenic trioxide by reducing intracellular glutathione concentrations.
Current medical research and opinion  •  2005  |  View Paper
Show More